Caricamento...
Cobimetinib‐induced “dropped head syndrome” and subsequent disease management in an Erdheim‐Chester patient
Our rechallenge of cobimetinib in an Erdheim‐Chester Disease (ECD) patient for the rare adverse effect, “dropped head syndrome,” with a previously unexplored cobimetinib regimen was successful. Similar to other experiences with targeted agents in ECD, dosing of cobimetinib may vary to mitigate toxic...
Salvato in:
| Pubblicato in: | Clin Case Rep |
|---|---|
| Autori principali: | , , , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
John Wiley and Sons Inc.
2019
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6787838/ https://ncbi.nlm.nih.gov/pubmed/31624624 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ccr3.2297 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|